Apeloa Pharmaceutical Co.,Ltd (SHE:000739)
China · Delayed Price · Currency is CNY 16.45
+0.05 (0.30%)
May 20, 2026, 11:34 AM CST
Apeloa Pharmaceutical Co.,Ltd Company Description
Apeloa Pharmaceutical Co.,Ltd researches and develops, produces, and sells pharmaceutical products in China and internationally.
It provides products in the cardio-cerebrovascular, anti-infection, anti-viral, anti-tumor, and other treatment areas.
The company offers preparations, raw material intermediates, and veterinary drugs primarily under the Tianliwei, Beshin, Yosemade, Jutai, and other brands.
It also provides contract research and development, and production services for pharmaceutical companies.
The company is headquartered in Dongyang, China.
Apeloa Pharmaceutical Co.,Ltd
| Country | China |
| Founded | 1989 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 6,787 |
| CEO | Fangmeng Zhu |
Contact Details
Address: No.399 Jiangnan Road Dongyang, Zhejiang Province Zhejiang Province China | |
| Phone | 86 579 8655 7527 |
Stock Details
| Ticker Symbol | 000739 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE000000Q45 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Fangmeng Zhu | Chief Executive Officer and Chairman |
| Chun He | President and Head of ACI BU |
| Min Jin | Senior Vice President |
| Lei Cai | Senior Vice President and Head of CDMO BU |
| Yuwang Zhou | Vice President and Secretary |
| Lihua Wu | Chief Financial Officer |
| Hui Zhang | Chief Technology Officer |
| Yonglong Li | Head of API BU |
| Liang Yu | Head of FDF BU |